EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+14.55%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.3B
AUM Growth
+$1.3B
(-0.24%)
Cap. Flow
-$181M
Cap. Flow
% of AUM
-13.88%
Top 10 Holdings %
Top 10 Hldgs %
62.01%
Holding
84
New
10
Increased
22
Reduced
31
Closed
17
Top Buys
| 1 |
GSK
GSK
|
$24.1M |
| 2 |
ZimVie
ZIMV
|
$20.7M |
| 3 |
Bausch Health
BHC
|
$12.5M |
| 4 |
Bio-Techne
TECH
|
$9.63M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$9.46M |
Top Sells
| 1 |
Inspire Medical Systems
INSP
|
$54.2M |
| 2 |
Natera
NTRA
|
$38.5M |
| 3 |
United Therapeutics
UTHR
|
$37.4M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$26.8M |
| 5 |
Novo Nordisk
NVO
|
$21M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vaxcyte
PCVX
$4B
| – | – | -96,089 | Closed | -$7.26M |
|
77
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
78
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
79
Terns Pharmaceuticals
TERN
$609M
| – | – | -286,266 | Closed | -$1.95M |
|
80
Viking Therapeutics
VKTX
$3.04B
| – | – | -138,489 | Closed | -$7.34M |
|
81
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | -100,000 | Closed | -$9.27M |
|
|
GTHX
82
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – | -199,963 | Closed | -$456K |
|
|
CERE
83
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| – | – | -110,010 | Closed | -$4.5M |
|
84
Fulcrum Therapeutics
FULC
$351M
| – | – | -152,965 | Closed | -$948K |
|